Most patients with ALK-negative anaplastic large cell lymphoma are adults aged between 40 and 65, with males being slightly more prone to developing the disease than females (M:F ratio 1.5:1) [95]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.